Within the vertebrate host the protozoan parasite is restricted almost exclusively to cells of the mononuclear phagocyte (reticuloendothelial) system, in which they are present as amastigotes. Two main clinical manifestations of leishmaniasis exist-cutaneous and visceral-the distribution of which is 0 shown in fig 1. In the cutaneous disease the parasites are restricted to macrophages of the skin, whereas in the visceral manifestation, though amastigotes may be found in many tissues, the major centres For many years progress on several aspects of leishmaniasis was handicapped by the difficulties of differentiating morphologically among the various species of Leishmania. Recent ultrastructural studies4 have shown differences in the size of amastigotes, but the main advance in identifying parasites has been the introduction of the techniques of biochemical taxonomy.56
The subdivision of the genus is complicated and to some extent controversial. An oversimplified classification includes L donovani, the causative organism of visceral leishmaniasis throughout the world. In India and some parts of East Africa transmission of this parasite is from man to man, while in other areas dogs and wild canids act as an animal reservoir. In the ution of cutaneous and visceral leishmaniasis.
Old World at least two organisms cause cutaneous leishmaniasis: L major is usually present in rural areas, with rodents acting as reservoirs, and is distributed from West Africa through the Middle East into the USSR, while L tropica is apparently more restricted in its distribution than L major, being present in North Africa, the Middle East, and the USSR. In the USSR in particular the parasite has an urban distribution and the transmission appears to be man to man. Recent studies indicate3 that in a few cases L tropica may give rise to a visceral infection instead of a simple cutaneous lesion. In the New World L mexicana and L braziliensis are responsible for cutaneous leishmaniasis; both species have been subdivided into numerous subspecies.
Though the basic outline of the life cycle is identical for all leishmanias infecting mammals, the details of the epidemiology Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool L3 5QA M L CHANCE, MSC, PHD, senior lecturer vary greatly, with many different species of vector and reservoir being involved with the various species of Leishmania.
The disease
The major symptoms of visceral leishmaniasis are intermittent fever, pronounced enlargement of the liver and spleen, anaemia, and leucopenia. Visceral leishmaniasis is sometimes known as kala-azar, a Hindu name for black fever that refers to the earthgrey pigmentation of the skin seen in some cases. Though it is difficult to obtain accurate figures, the infection is thought to be fatal in at least 70% of untreated cases.7 Superinfection is an important cause of death.
In cutaneous leishmaniasis a nodule appears at the site exposed to the bite of infective sandflies. A shallow ulcer forms (fig 2) , usually about 2X5 cm in diameter, though in some instances an area several centimetres across may be eroded. 
The diagnosis of leishmaniasis usually depends on finding Giemsa-stained amastigotes in biopsy material taken from bone marrow or the spleen. This material may also be cultured in blood-agar medium (known as NNN) at 26°C, when the presence of promastigotes in the culture confirms infection with leishmania. Serological methods of diagnosis, including indirect immunofluorescence (IFAT) and enzyme-linked immunosorbent assay (ELISA), have been extensively investigated,9 10 but, though they have proved sensitive, they lack specificity, exhibiting in some cases extensive cross-reactivity with other common infectious organisms including mycobacteria and trypanosomes. 1' 12 There is a great need for more specific serodiagnostic techniques for leishmaniasis.
Treatment and control
The first effective treatment of leishmaniasis was achieved with the antimonial tartar emetic. The present drugs of choice are still antimonials-the pentavalent antimonials sodium antimony gluconate (Pentostam) and antimony methyl glucantime (Glucantime). Amphotericin B and pentamidine are also used in antimony-resistant cases, which may be frequent in some geographical regions. There is an obvious need for a wider range of less toxic drugs for treating leishmaniasis.
The control of leishmaniasis by interrupting the transmission cycle can in many cases present almost insurmountable problems. 13 Though no new drugs have been developed for treating leishmaniasis, there has been an important development in the delivery of drugs. Though still used only in experimental systems, the use of liposomes (phospholipid dispersions) to encapsulate antileishmanial drugs has greatly increased, by several hundredfold, the efficacy of drugs administered in this manner.'6-'8 The use of liposomes increases the efficacy of several drugs in both the cutaneous and visceral forms.19 The rationale behind this method of administration is that intravenously administered liposomes are rapidly removed from the blood stream by the phagocytic cells of the liver and spleen. These are the very cells that in the visceral disease contain the parasites; thus high concentrations of drug are achieved in the vicinity of the parasite. Indeed, since lysosomal fusion occurs with the vacuole containing the parasite,20 and since phagocytosed liposomes themselves will be present in lysosomes, there is the possibility of drug being delivered directly into the vacuole containing the amastigote.
We have also witnessed a tremendous increase in our knowledge of the epidemiology of leishmaniasis in many parts of the world. Thus, for example, the importance of rodents and carnivores as reservoirs of human visceral disease in the Sudan 27 allows large numbers of the mammalian stage of the parasite to be available for experimental studies. Unfortunately not all species of Leishmania can be easily handled in the laboratory and no convenient laboratory host has been found for L braziliensis, while the same parasite is also difficult to culture in vitro-which has serious implications, for example, in the preparation of antigens to be used in vaccination.
Problems relating to the identification of leishmania have been overcome by using the techniques of biochemical taxonomy, which include determining the buoyant density of DNA and the electrophoretic mobility of specific enzymes. The techniques have proved particularly useful in identifying parasites isolated from potential vectors and reservoirs.28 A recent advance in the identification of New World leishmania has been the production of monoclonal antibodies specific for either L mexicana or L braziliensis.29 These antibodies should prove useful for either the identification or the direct diagnosis of leishmaniasis. Clearly the areas in which the most rapid advances are being made are in investigations on the parasite itself rather than medical topics. Many of the studies on the parasite, particularly those on experimental chemotherapy and immunodiagnosis, could rapidly be translated into medical advances.
Is sclerotherapy or surgery the most effective treatment for hydrocele ?
Either sclerotherapy or surgery is effective in the treatment of hydrocele. On the other hand, it should be remembered that the thin-walled sac of a hydrocele that has been tapped infrequently in a younger patient will undergo considerable inflammation as a result of the action of the sclerosing agent. This can be exquisitely painful for the patient for several hours, or even one or two days. The older patient whose hydrocele has been tapped many times and may have had infection in the past will have a thicker-walled sac, and in this type the sclerosing agent causes minimal discomfort to the patient. Surgery may be done under local anaesthesia and through a relatively small incision if the hydrocele sac wall is thin. Bleeding and infection are the two commonest complications of excision of hydrocele and therefore every care should be taken to ensure complete haemostasis by oversewing the margin where the sac has been excised. Recurrence of hydrocele is distinctly more common after sclerotherapy than surgery because the sclerosing agent may not diffuse evenly throughout the whole of the sac.-J P MITCHELL, honorary professor of surgery (urology), Bristol.
